Loss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency.

scientific article published on 5 May 2016

Loss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/PIN.12414
P698PubMed publication ID27150549

P50authorShinji UemotoQ91614513
P2093author name stringMureo Kasahara
Hironori Haga
Aya Miyagawa-Hayashino
Toru Yorifuji
Atsuko Nakazawa
Sachiko Minamiguchi
Tatsuki R Kataoka
Takaki Sakurai
Akinari Fukuda
Maki Yamaguchi
Takahiro Shibayama
P2860cites workDetection of carbamyl phosphate synthetase 1 deficiency using duodenal biopsy samplesQ24302968
Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerationsQ27334840
Quality control of mRNA functionQ34156109
The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1.Q34655404
The frequent observation of evidence for nonsense-mediated decay in RNA from patients with carbamyl phosphate synthetase I deficiencyQ40273401
Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseasesQ46455730
Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiencyQ50175661
P433issue6
P304page(s)333-336
P577publication date2016-05-05
P1433published inPathology InternationalQ15758750
P1476titleLoss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency.
P478volume66

Search more.